News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Fontenot Jason D.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| Fontenot Jason D. (SVP, Chief Scientific Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 1,029 shares
@ $1.33, valued at
$1.4k
|
|
| 03/06/2023 |
4
| Fontenot Jason D. (SVP, Chief Scientific Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 42,750 shares
@ $0
Paid exercise price by delivering 6,559 shares
@ $2.66, valued at
$17.4k
Granted 199,500 options to buy
@ $2.66, valued at
$530.7k
|
|
| 04/27/2022 |
4
| Fontenot Jason D. (SVP, Chief Scientific Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 826 shares
@ $4.83, valued at
$4k
|
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|